Thanks, brief section on CHM.. key take out from that snippet is that Paul Hopper just confirmed that they plan to finish up the phase 1 trial in 2022... that means finish off the cohort 3 which they just commenced and cohort 4. So they may be in the pivotal phase 2 trial in 2023... and that is where partnerships/take-overs come into play... assuming the data from the phase 1 trial is strong of course
Exciting times... 2022 is going to be a big year for CHM.. but 2023 probably even bigger!
Thanks, brief section on CHM.. key take out from that snippet is...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $20.21K | 5.053M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2213046 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 13563373 | 20 |
View Market Depth
| Last trade - 15.01pm 24/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |